LBX2 and central nervous system cancer: Recent studies revealed that in glioma tissue samples and cancer cell lines, LBX2-AS1 was detected to increase critically through qRT-PCR and FISH (Fluorescence in situ hybridization), and its overexpression was significantly correlated with poor prognosis and malignant progression among patients with glioma [32, 51, 99].